Poor sleep can make anxiety feel louder, and anxiety can make it harder to fall or stay asleep. The first steps are usually practical: steady sleep habits, then cognitive behavioral therapy for persistent insomnia, and a mental health evaluation when anxiety is hard to manage or starts disrupting daily life.
CDC’s December 2025 change on hepatitis B shots for some newborns did not change a separate recommendation for adults: people 18 and older should still get screened at least once with a triple-panel blood test. The test can find infections that cause no symptoms for years and help prevent long-term liver disease.
CMS began enforcing updated hospital price-transparency rules on April 1, 2026. The goal is to make hospital pricing files more usable for patients and shoppers, but it does not remove every source of surprise billing or confusion. Here’s what changed, what CMS says it may improve, and what readers should still check before non-emergency hospital care.
The FDA has proposed removing semaglutide, tirzepatide, and liraglutide from a list that helps some large compounding facilities legally make GLP-1 drugs from bulk ingredients. The agency says it did not find a clinical need for that pathway, and it is asking for public comments through June 29, 2026. For patients who rely on compounded GLP-1 medicines, the change could affect access, pricing, and refill planning—but it is not final yet.
Older adults may need several routine vaccines in 2026, including RSV, pneumococcal, shingles, flu, and possibly COVID-19. The right schedule depends on age, prior shots, and health conditions, and timing can matter for RSV and seasonal respiratory viruses.
CDC now recommends one RSV vaccine dose for all adults 75 and older, with the best timing in late summer or early fall before RSV usually spreads widely. For many older adults, the practical question is how to fit RSV protection into a fall vaccine visit alongside flu and COVID-19 shots.
CMS and HHS have announced new rural health funding, while CMS is also moving ahead with hospital price transparency updates and a proposed rule on Medicaid managed care and fee-for-service payments. For patients, the biggest near-term effects could show up in access, provider payments, and how clearly hospitals must post prices, though details will vary by state, plan, and facility.
The FDA posted two hospital-level recalls of injectable products in late April and mid-May 2026. One involved doxorubicin liposome injection with possible glass particles; the other involved Lactated Ringer’s Injection with particulate matter. The notices matter most for hospitals, pharmacies, and infusion teams, but patients can ask whether any planned treatment is affected.
CDC says flu vaccination is available for people 6 months and older, and early 2025–2026 data suggest the shots offered meaningful but partial protection. Families can save time and stress by checking age-based vaccine schedules now, before fall respiratory-virus season ramps up.
Falls remain one of the biggest injury risks for adults 65 and older, and CDC says the age-adjusted fall death rate rose from 64.7 per 100,000 in 2018 to 78.4 in 2024. The good news: many falls can be prevented with the right mix of exercise, medication review, vision care, and home safety.
A JAMA trial found that, for some newborns treated for opioid withdrawal, giving medicine based on symptoms instead of a fixed taper shortened the time to medical readiness for discharge. The study was done in U.S. hospitals already using Eat, Sleep, Console or Finnegan-based care, and experts say families still need careful discharge planning and follow-up.
CMS has started rolling out a $50 billion rural health program that will flow through states, not directly to patients or hospitals. That means the biggest question for rural communities is not just how much money is available, but how each state chooses to use it. The program could affect hospital services, primary care, telehealth, workforce shortages, and local costs over time, but state plans are still being built and results will vary widely.
A routine dental visit can include a quick mouth, head, and neck exam that may spot trouble early. But U.S. agencies do not recommend a universal stand-alone screening test for every symptom-free adult, because evidence is still insufficient. Here’s how to think about the exam, who should pay closer attention, and what to ask at your next visit.
A multistate E. coli outbreak linked to raw cheddar cheese and raw milk has ended, but recalled products may still be in home refrigerators and freezers. Here’s what the CDC and FDA said, who is most at risk, and what consumers should do if they bought the cheese.
Seasonal allergies are common in the United States, and pollen seasons can feel tougher in warm, high-pollen weeks. Simple steps can reduce exposure, and antibiotics do not treat seasonal allergies.
CMS began enforcing updated hospital price-transparency requirements in April 2026. The change is meant to make hospital price files more usable, but it does not guarantee an easy shopping experience or a lower bill for every patient.
The FDA has posted a Class II recall for specific lots of the QuickVue Dipstick Strep A Test. The action matters because rapid strep tests help guide next steps for sore throats, and a negative result is not always the final word — especially in children and teens with symptoms.
CMS has proposed new electronic prior-authorization rules for drugs that could shorten some approval waits, but the change is not final. The plan would still need public comments, a final rule, and plan-by-plan implementation before patients see any effect.
Asthma symptoms that ease on weekends or vacations and return at work can be a clue that your job is part of the problem. Here’s how work-related asthma is recognized, what can trigger it, and why both exposure control and medical care matter.
Marketplace coverage remains widely used, but many 2026 shoppers are seeing a less generous mix of plans and higher out-of-pocket costs than they did when enhanced premium tax credits were in place. CMS says 23.1 million people selected or were re-enrolled in Marketplace coverage for 2026, even as bronze plan selections rose and silver selections fell.
B. Braun Medical has recalled specific lots of Lactated Ringer’s Injection, 1L, after FDA said the product may contain particulate matter. The recall affects hospitals and other healthcare facilities; patients who recently received this IV fluid can ask their care team whether the recalled lots were used.
The FDA says certain TRUE METRIX blood glucose monitoring systems need updated instructions for an E-5 error code. For people who rely on quick glucose readings to make diabetes decisions, the alert matters because a meter problem can delay recognition of very low or very high blood sugar.
End of content
End of content
